BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesBrandPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsRed Cell Genotyping Services Framework
    Awarded contract

    Red Cell Genotyping Services Framework

    Awarded
    £1.6m
    Published 10 Jul 2026

    Tender for red cell genotyping platform to support NHS and UK blood services in identifying blood groups for complex transfusion cases.

    🇬🇧United Kingdom· South WestPublished 10 Jul 2026· 1 months agoviaFind a Tender
    Awarded
    £1.6m
    Published 10 Jul 2026

    Decision brief

    4 fields
    • Contract value
      £1,585,933
      Pounds sterling
    • Closing date
      Rolling
      No closing date published
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇬🇧United Kingdom
      South West

    Suppliers

    1 supplier
    • SB
      Sussex Biological Limited
    Lead contractor

    Lifecycle

    Awarded

    Contract awarded. Originally published 1 months ago.

    10 July 2026
    Awarded — no open tender advertised

    Brief

    NHS Blood & Transplant (NHSBT), Scottish National Blood Transfusion Service (SNBTS), Welsh Blood Service, and Northern Ireland blood services are seeking a supplier for red cell genotyping methods to support their reference laboratories. These services diagnose and manage complex blood transfusion cases, particularly for patients whose red cell phenotype cannot be determined through standard methods due to prior transfusions, monoclonal antibody treatments, or autoimmune conditions. Red cell genotyping uses molecular techniques to determine blood groups and is critical for urgent patient care. The supplier must provide: extended red cell genotype testing for multiple blood group systems; detection of weak and partial Rh D variants; either closed or open system platforms; capability to process batches efficiently while minimizing waste from smaller test runs; turnaround time under 24 hours from DNA extraction to results; and quality assurance including CE marking. The framework will serve reference laboratories across the UK, including sites in England (Barnsley, Birmingham, Colindale, Bristol, Liverpool, Newcastle, and Tooting), Scotland (Aberdeen, Dundee, Edinburgh, Glasgow, and Inverness), Wales, and Northern Ireland, with red cell genotyping centralized at the Glasgow site in Scotland.

    Track record

    9 awards · 9 winners
    Open field

    No single supplier dominates the field.

    In healthcare medical, NHS BLOOD AND TRANSPLANT has awarded 9 contracts to 9 suppliers.

    Who wins here
    1. LAUNCH DIAGNOSTICS LIMITED1× · 11%
    2. QIAGEN LTD1× · 11%
    3. Sussex Biologicals Ltd1× · 11%
    4. Sussex Biological Limited1× · 11%
    5. Oxford Nanopore Technologies Plc1× · 11%
    6. Alpha Laboratories Ltd1× · 11%

    +3 more suppliers

    Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.

    More from NHS BLOOD AND TRANSPLANT

    4 listingsView all →
    OpenHealthcare & Medical🇬🇧United Kingdom

    Supply, Installation and Maintenance of Platelet Storage Equipment

    NHS Blood and Transplant seeks supplier feedback on platelet agitator and incubator equipment options to inform a future multi-lot procurement for new equipment supply and maintenance of existing systems across England.

    £1,500,000indicativeNHS BLOOD AND TRANSPLANT
    Published 27 Aug 2026
    AwardedHealthcare & Medical🇬🇧United Kingdom

    Digital PCR Equipment, Consumables, and Maintenance Services

    Opportunity to supply digital PCR equipment, consumables, and maintenance services to support molecular biology research and diagnostic capabilities.

    £1,267,857NHS BLOOD AND TRANSPLANT
    Published 26 Aug 2026
    AwardedIT & Software🇬🇧United Kingdom

    EMDIS and WMDA Match-Connect Platform License, Support, and Maintenance Services

    Provision of licensed access, technical support, and ongoing maintenance for EMDIS and WMDA Match-Connect platforms to ensure reliable and secure donor registry operations.

    £284,738NHS BLOOD AND TRANSPLANT
    Published 17 Aug 2026
    AwardedIT & Software🇬🇧United Kingdom

    Risk Management System Implementation

    Procurement of a Risk Management System to help organizations identify, assess, and mitigate operational and business risks.

    £168,553NHS BLOOD AND TRANSPLANT
    Published 14 Aug 2026

    Open in Healthcare & Medical

    4 open listingsView all →
    OpenHealthcare & Medical🇬🇧United Kingdom

    Urgent Treatment Centre Services - York and Scarborough Teaching Hospitals

    NHS teaching hospital trust seeks qualified providers for urgent treatment centre services across multiple sites, with contract value up to £2.5m annually and start date of April 2027.

    £12,500,000indicativeYork and Scarborough Teaching Hospital NHS Foundation Trust
    Published 2 Sept 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Work and Health Early-Intervention Service Market Engagement Event – Nottinghamshire, Lincolnshire and Derbyshire

    Join a virtual market engagement event on 14 September 2026 to discuss delivering a £10 million work and health early-intervention service across Nottinghamshire, Lincolnshire and Derbyshire.

    £10,000,000indicativeNHS NOTTINGHAM AND NOTTINGHAMSHIRE INTEGRATED CARE BOARD
    Published 2 Sept 2026
    Healthcare & Medical🇬🇧United Kingdom

    General Dental Services Tender - Gwent

    Tender opportunity to provide General Dental Services across Gwent under the Aneurin Bevan University Health Board.

    est.£6,100,000Aneurin Bevan University Health Board
    Published 2 Sept 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    NHS Ruxolitinib Supply Framework Agreement

    NHS England is seeking a supplier framework agreement for Ruxolitinib, a pharmaceutical product, for the period April 2028 to March 2029 with possible extension.

    est.£105,900,000NHS ENGLAND
    Published 2 Sept 2026
    Take action
    View on sourceFind a Tender

    Award notice and full record on the publisher's site

    Publisher
    UK Cabinet Office
    Licence
    OGL v3.0
    Source
    find-tender.service.gov.uk
    Record ID
    ocds-h6vhtk-051ec0
    NB
    Buyer
    NHS BLOOD AND TRANSPLANT
    Sector
    Healthcare & Medical